AIOCD urges GoM to speed up national pharmaceutical pricing policy decision
Seeks to determine prices at which pharmaceutical companies sell essential medicines in the retail market
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Merck withdraws European filing for Erbitux in NSCLC
Decision based on demand for more data from European regulatory authorities
IMCD acquires pharmaceutical business of Maxwell Pharma in Malaysia
The acquisition process will be closed on September 30, 2012
Scientists create first ever 3-D ‘pancreas in a dish’
Microscopic 3-D model will allow researchers to see how pancreatic cancer develops
Strategies for success in China outlined in new Quintiles-sponsored report by Economist Intelligence…
Local presence and proactive regulatory approaches needed
M&A or MIA?
After witnessing watershed deals in the past few years, the M&A scenario in India seems to be MIA: missing in action. However,…
Venus Remedies bags patent for Vancoplus from Canada
Venus Remedies has secured its first patent from Canada for its novel antibiotic adjuvant entity ‘Vancoplus’.
CDSCO to increase headcount of NDAC, MDAC committees
The last date for submitting the applications are on September 28, 2012
Orchid Pharma signs agreement with Hospira for $200 m
To transfer its penicillin and penem API business and its API facilities in Aurangabad
US FDA to continue review of Crofelemer new drug application
FDA action on Crofelemer NDA anticipated by end of 1Q-CY2013